| ISIN | CH1416135353 |
|---|---|
| Valor Number | 141613535 |
| Bloomberg Global ID | CHDIVA SW |
| Fund Name | UBS ETF (CH) - UBS MSCI Swiss Dividend ETF CHF acc |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 3.31 CHF | 20.01.2026 |
|---|---|---|
| Previous Price * | 3.33 CHF | 19.01.2026 |
| 52 Week High * | 3.36 CHF | 21.03.2025 |
| 52 Week Low * | 2.88 CHF | 09.04.2025 |
| NAV * | 3.31 CHF | 20.01.2026 |
| Issue Price * | 3.31 CHF | 20.01.2026 |
| Redemption Price * | 3.31 CHF | 20.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 51,261,312 | |
| Unit/Share Assets *** | 4,577,115 | |
| Trading Information SIX | ||
| YTD Performance | +0.18% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
|---|---|---|
| 1 month | +0.82% |
22.12.2025 - 20.01.2026
22.12.2025 20.01.2026 |
| 3 months | +4.38% |
20.10.2025 - 20.01.2026
20.10.2025 20.01.2026 |
| 6 months | +5.27% |
21.07.2025 - 20.01.2026
21.07.2025 20.01.2026 |
| 1 year | -1.52% |
21.03.2025 - 20.01.2026
21.03.2025 20.01.2026 |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 16.78% | |
|---|---|---|
| Novartis AG Registered Shares | 15.42% | |
| Zurich Insurance Group AG | 13.96% | |
| Nestle SA | 12.87% | |
| Swiss Re AG | 11.70% | |
| Partners Group Holding AG | 9.95% | |
| Helvetia Baloise Holding AG | 6.37% | |
| SGS AG | 6.34% | |
| Swisscom AG | 6.17% | |
| Kuehne + Nagel International AG | 3.56% | |
| Last data update | 16.01.2026 | |
| TER | 0.12% |
|---|---|
| TER date | 15.10.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.20% |
| Ongoing Charges *** | 0.20% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |